MiCell Technologies, Inc.

CRITICOAT

Coating services for others, namely, application of chemical, lubricant, lubricious, gas, liquid, polymer and hydrophilic polymer coatings to medical devices; application of coatings for others to a wide variety of medical devices; coating services in the nature of incorporating drugs and bioactive agents into coating formulations and applying them to medical devices;Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticals, cells and tissue;CRITICAL COAT;Chemicals and chemical solutions for use in the manufacture of coatings for medical and biomedical applications and devices; chemicals and chemical solutions for use in the manufacture of drug delivery coatings; chemicals and chemical solutions for stabilizing biological molecules for scientific or medical research use;Developments for others of chemical, lubricant, lubricious, gas, liquid, polymer and hydrophilic polymer coating formulations;

CRITIFLO

Coating services for others, namely, application of chemical, lubricant, lubricious, gas, liquid, polymer and hydrophilic polymer coatings to medical devices; application of coatings for others to a wide variety of medical devices; coating services in the nature of incorporating drugs and bioactive agents into coating formulations and applying them to medical devices;Drug delivery matrices consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; cell and tissue delivery matrices consisting of compounds that facilitate delivery of cells and tissue to the body; naturally biodegradable matrix used as a carrier for pharmaceuticals, cells and tissue;Chemicals and chemical solutions for use in the manufacture of coatings for medical and biomedical applications and devices; chemicals and chemical solutions for use in the manufacture of drug delivery coatings; chemicals and chemical solutions for stabilizing biological molecules for scientific or medical research use;Developments for others of chemical, lubricant, lubricious, gas, liquid, polymer and hydrophilic polymer coating formulations;

ECO2

Washing machines using carbon dioxide for clothes and treatment and cleaning of fabrics and textiles; machines using carbon dioxide for dry-cleaning;

M

Machinery for industrial and commercial use, namely, machines for the use of carbon dioxide in the dry-cleaning, garment cleaning, metal cleaning and textile treatment industries;M;The drawing is lined for the color blue.;

M

M;Chemicals, excluding alkali metal silicates, namely, surfactants for use in surface preparation, industrial chemical processing, recycling, waste management, industrial chemical separation, extraction and dispersion in the plastics industry, the textile industry, the automotive industry, and the metal finishing industry and surface coating, namely, fabric protectant for use in dry cleaning;The drawing is lined for the color blue.;

M

The mark consists of letter M surrounded by an abstract design.;drug delivery agents in the form of coatings for medical devices in the nature of stents, dressings, bandages, catheters, valves, patches, braces, wires and tubing that facilitate the delivery of a wide range of pharmaceuticals;MICELL; MY CELL;Color is not claimed as a feature of the mark.;catalysts for use in the manufacture of polymers; polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, plastics, cosmetics, medical devices, personal care products, industrial products, consumer and household products, coatings, adhesives, and lubricants;medical and surgical devices, apparatus and instruments, namely, drug-eluting stents; coatings sold as an integral component of medical stents and other internal and external medical devices for cardiac, vascular and orthopedic treatments;medical and scientific research in the field of drug eluting technologies and combination product therapies;